Financials Vicplas International Ltd
Equities
569
SG1G57870584
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 SGD | -4.96% | +5.50% | -22.82% |
Valuation
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 55.07 | 37.89 | 70 | 104.7 | 99.66 | 75.13 |
Enterprise Value (EV) 1 | 50.01 | 42.32 | 78.77 | 113.7 | 118 | 83.49 |
P/E ratio | 18.6 x | 8.95 x | 14.1 x | 10.3 x | 11.5 x | 17.9 x |
Yield | 6.88% | 6.67% | 2.72% | 2.2% | 2.31% | 3.06% |
Capitalization / Revenue | 0.77 x | 0.45 x | 0.76 x | 0.88 x | 0.73 x | 0.56 x |
EV / Revenue | 0.7 x | 0.51 x | 0.86 x | 0.95 x | 0.86 x | 0.63 x |
EV / EBITDA | 9.54 x | 5.16 x | 7.62 x | 6.92 x | 7.03 x | 6.22 x |
EV / FCF | -8.27 x | -5.33 x | 56.2 x | -929 x | -17.1 x | 7.19 x |
FCF Yield | -12.1% | -18.7% | 1.78% | -0.11% | -5.86% | 13.9% |
Price to Book | 0.95 x | 0.63 x | 1.13 x | 1.46 x | 1.27 x | 0.96 x |
Nbr of stocks (in thousands) | 505,217 | 505,217 | 507,217 | 510,627 | 511,077 | 511,077 |
Reference price 2 | 0.1090 | 0.0750 | 0.1380 | 0.2050 | 0.1950 | 0.1470 |
Announcement Date | 11/2/18 | 11/11/19 | 11/3/20 | 11/1/21 | 11/1/22 | 11/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 71.26 | 83.46 | 91.76 | 119.5 | 136.6 | 133.5 |
EBITDA 1 | 5.243 | 8.196 | 10.34 | 16.44 | 16.79 | 13.42 |
EBIT 1 | 1.671 | 4.258 | 5.924 | 11.63 | 11.85 | 8.31 |
Operating Margin | 2.34% | 5.1% | 6.46% | 9.73% | 8.68% | 6.23% |
Earnings before Tax (EBT) 1 | 1.58 | 3.978 | 7.17 | 12.3 | 11.01 | 5.609 |
Net income 1 | 2.95 | 4.236 | 4.984 | 10.4 | 8.839 | 4.238 |
Net margin | 4.14% | 5.08% | 5.43% | 8.7% | 6.47% | 3.18% |
EPS 2 | 0.005861 | 0.008384 | 0.009799 | 0.0200 | 0.0170 | 0.008200 |
Free Cash Flow 1 | -6.048 | -7.935 | 1.401 | -0.1224 | -6.917 | 11.61 |
FCF margin | -8.49% | -9.51% | 1.53% | -0.1% | -5.07% | 8.7% |
FCF Conversion (EBITDA) | - | - | 13.54% | - | - | 86.5% |
FCF Conversion (Net income) | - | - | 28.1% | - | - | 273.97% |
Dividend per Share 2 | 0.007500 | 0.005000 | 0.003750 | 0.004500 | 0.004500 | 0.004500 |
Announcement Date | 11/2/18 | 11/11/19 | 11/3/20 | 11/1/21 | 11/1/22 | 11/6/23 |
Balance Sheet Analysis
Fiscal Period: July | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 4.43 | 8.77 | 9.01 | 18.4 | 8.37 |
Net Cash position 1 | 5.06 | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | 0.5406 x | 0.8483 x | 0.5483 x | 1.093 x | 0.6233 x |
Free Cash Flow 1 | -6.05 | -7.93 | 1.4 | -0.12 | -6.92 | 11.6 |
ROE (net income / shareholders' equity) | 5.06% | 7.04% | 8.01% | 15.6% | 11.8% | 5.4% |
ROA (Net income/ Total Assets) | 1.46% | 3.4% | 4.27% | 7.17% | 6.12% | 4.17% |
Assets 1 | 201.9 | 124.4 | 116.8 | 145.1 | 144.4 | 101.7 |
Book Value Per Share 2 | 0.1100 | 0.1200 | 0.1200 | 0.1400 | 0.1500 | 0.1500 |
Cash Flow per Share 2 | 0.0200 | 0.0100 | 0.0100 | 0.0200 | 0.0200 | 0.0200 |
Capex 1 | 6.54 | 8.16 | 6.42 | 5.16 | 12.5 | 5.29 |
Capex / Sales | 9.17% | 9.78% | 6.99% | 4.32% | 9.15% | 3.96% |
Announcement Date | 11/2/18 | 11/11/19 | 11/3/20 | 11/1/21 | 11/1/22 | 11/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.82% | 43.17M | |
+72.92% | 12.38B | |
-19.68% | 7.92B | |
+16.20% | 7.2B | |
+6.78% | 5.84B | |
+7.49% | 5.07B | |
+23.97% | 4.53B | |
-19.42% | 3.88B | |
-41.54% | 2.23B | |
+1.24% | 2.02B |
- Stock Market
- Equities
- 569 Stock
- Financials Vicplas International Ltd